Main Menu

Walker brings Molecular Genetics Expertise to the Myeloma Institute

Aspecialist in molecular immunology and molecular genetics, Brian Walker, Ph.D., left his native United Kingdom (UK) in October 2015 to join the Myeloma Institute as professor of medicine and director of research. As a high school student in Scotland, Walker expected he would pursue a career in mathematics until “a good biology teacher changed all [...]

May 6th, 2016|Myeloma Magazine, Spring 2016, Uncategorized|

Research Grant Awarded To Dr. Schinke

Carolina Schinke, M.D., assistant professor at the Myeloma Institute, has been awarded a 2016 UAMS Medical Research Endowment Fund grant. Grants from the Medical Research Endowment Fund provide pilot research funding that has the potential to develop into extramurally funded, scientifically significant research projects. Support is focused on new areas of research for young faculty investigators [...]

May 6th, 2016|Myeloma Magazine, Spring 2016, Uncategorized|

Fighting Back to Good Health

The ability to get up after being knocked down and rise to new heights is an attribute that can help shape our lives and help us cope with life’s challenges. Chuck Cordell knows first-hand the value of this attribute. When struck with adversity, he faced it head on, drew from his inner core to fight [...]

May 6th, 2016|Myeloma Magazine, Spring 2016, Uncategorized|

Supporting the Whole Patient

Harold Dean counsels a patient after treatment. A diagnosis of a cancer like myeloma can be devastating. Fear of the unknown, uncertainty about the future, and concerns about how everyone — patient and loved ones — will be affected can be overwhelming.  While doctors and nurses can offer encouragement and information about what [...]

May 6th, 2016|Myeloma Magazine, Spring 2016, Uncategorized|

behind the scenes

Tarun Garg, Ph.D. Dr. Garg earned a Ph.D. in Zoology from Banaras Hindu University in India and completed post-doctoral fellowships in Neurobiology and Developmental Sciences and Multiple Myeloma at the University of Arkansas for Medical Sciences. Dr. Garg’s research is focused on developing highly activated expanded natural killer (ENK) cell therapy for high-risk relapsed multiple [...]

May 6th, 2016|Myeloma Magazine, Spring 2016, Uncategorized|

Myeloma Awareness Month Upcoming Activities

St. Patrick’s Day Bake Sale to benefit Patient Support Sponsored by Myeloma Institute Social Work Dept. Thursday, March 17th Myeloma Institute Clinic and F7 Inpatient Unit Fighting for a Cure with Captain America Yoga, refreshments, and more! Sponsored by Infusion 4 Tuesday, March 29th Cancer Institute 4th Floor, Infusion 4 MARCHing for a Cure Entertainment [...]

March 15th, 2016|News, Uncategorized|

Geneticist Brian Walker, Ph. D., Joins UAMS Myeloma Institute

Brian Walker, Ph. D. LITTLE ROCK – Brian Walker, Ph.D., has joined the University of Arkansas for Medical Sciences (UAMS) as a professor of medicine in the College of Medicine and director of the Myeloma Institute’s basic research team. Walker’s most recent post was as a senior research scientist with the Centre for [...]

March 3rd, 2016|News, Uncategorized|

With FDA approved new Immunotherapy Drugs for Myeloma, are Auto and Allo Transplants on the Way Out?

In just the past 2 months, 3 new drugs for myeloma treatment have been approved by the FDA. With so many more options for immunotherapy drugs coming up, will transplants continue to be an integral part of myeloma treatment? Tune in December 15th at 10 am ET to listen to myeloma advocates and survivors discuss [...]

December 10th, 2015|News, Uncategorized|

Handling the Holidays Event on December 3

The Myeloma Institute Social Work  Department will host a Patient Support Seminar entitled “Handling the Holidays – a gift of healthy tips” on Thursday, December 3  from 5:30 – 7:00 PM.   The seminar will be held in the Betsy Blass Boardroom on the 10th floor of the Cancer Institute and refreshments will be provided.

November 18th, 2015|News, Uncategorized|

FDA approves Darzalex for patients with previously treated multiple myeloma

Today the U.S. Food and Drug Administration granted accelerated approval for Darzalex (daratumumab) to treat patients with multiple myeloma who have received at least three prior treatments. Darzalex is the first monoclonal antibody approved for treating multiple myeloma. Read more here: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm472875.htm  

November 17th, 2015|News, Uncategorized|